Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × Brachytherapy × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 21 Uterine Cervical Neoplasms 13 Endometrial Neoplasms 4 Esophageal Neoplasms 3 Vaginal Neoplasms 2 Rhabdomyosarcoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Uveal Melanoma 1 Recurrent Head and Neck Carcinoma 1 Recurrence 1 Radiation Injuries 1 Prostatic Diseases 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Metastatic Malignant Female Reproductive System Neoplasm 1 Locally Advanced Cervical Adenocarcinoma 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Clear Cell Adenocarcinoma 1 Desmoplastic Small Round Cell Tumor 1 Carcinosarcoma 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1 Adenocarcinoma 1

Interventions

Bevacizumab 59 atezolizumab 51 durvalumab 37 lenvatinib 35 pembrolizumab 33 Nivolumab 28 tremelimumab 23 Magnetic Resonance Spectroscopy 18 Specimen Handling 16 Sorafenib 16 Ipilimumab 13 tislelizumab 12 regorafenib 12 cabozantinib 12 apatinib 11 Radiosurgery 11 Immune Checkpoint Inhibitors 11 sintilimab 10 camrelizumab 9 Blood Specimen Collection 9 Radiotherapy 8 Immunoglobulin G 7 Cyclophosphamide 7 X-Rays 6 Hepatectomy 6 Disulfides 6 donafenib 5 Surgical Procedures, Operative 5 Fluorouracil 5 fludarabine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡